Poor Glycemic Control Induces Hypertension in Diabetes Mellitus
Overview
Authors
Affiliations
We conducted this study to test the hypothesis that hypertension is a primary consequence of poor glycemic control per se very early in insulin-dependent diabetes mellitus. Sprague-Dawley rats (n=15) were instrumented with artery and vein catheters, placed in metabolic cages, and sodium intake was clamped throughout the study. Mean arterial pressure was measured 24 h/d. After a precontrol period, streptozotocin (70 mg/kg IV) was administered, and 15 hours later a continuous intravenous infusion was begun at 4 U/rat per day. The insulin infusion was titrated on an individual rat basis to maintain good glycemic control, and after this 7-day control period, blood glucose, urinary sodium excretion, and mean arterial pressure were not different from precontrol values, averaging 8.8 +/- 0.6 mmol/L, 2.8 +/- 0.2 mmol/d, and 103 +/- 2 mm/Hg, respectively, for control days 5 through 7. Subsequently, a 4-day period of poor glycemic control was initiated by reducing the insulin infusion rate. Blood glucose, urinary sodium excretion, and mean arterial pressure began to increase on day 1; for diabetes days 3 and 4, they averaged 23.4 +/- 1.0 mmol/L, 3.6 +/- 0.1 mmol/d, and 110 +/- 2 mm Hg, respectively. All were significantly elevated. When insulin treatment was restored, all variables returned to control levels during the next 4 days. A second 4-day diabetic period yielded similar results. These results indicate that elevated blood pressure is a primary consequence of poor glycemic control in insulin-dependent diabetes, occurring before renal injury has had time to develop, and therefore, may be a factor contributing to the initiation of end-organ injury.
Adegoke O, Bello B, Olorunfemi G, Odeniyi I Ann Afr Med. 2022; 21(4):348-354.
PMID: 36412333 PMC: 9850889. DOI: 10.4103/aam.aam_78_21.
Dedefo M, Gemechu D, Fekadu G, Tekle Dibessa T Int J Hypertens. 2020; 2020:7526257.
PMID: 32637172 PMC: 7322590. DOI: 10.1155/2020/7526257.
Pojoga L, Yao T, Opsasnick L, Garza A, Reslan O, Adler G J Pharmacol Exp Ther. 2013; 348(2):260-70.
PMID: 24281385 PMC: 3912545. DOI: 10.1124/jpet.113.209189.
Cardiopulmonary Profile in Streptozotocin-Induced Type 1 Diabetic Rats during Systemic Endotoxemia.
Hung C, Chang C, Chen Y, Chen Y, Tzeng J, Wang J J Diabetes Res. 2013; 2013:494179.
PMID: 23671873 PMC: 3647548. DOI: 10.1155/2013/494179.
Chaabo F, Pronczuk A, Maslova E, Hayes K Nutr Metab (Lond). 2010; 7:29.
PMID: 20398338 PMC: 2868017. DOI: 10.1186/1743-7075-7-29.